Purpose: This article presents the study and simulation results of a millimeter (mm)-wave device for cancerous tissue detection. mm-Wave approach ensures cheaper equipment instead of the traditional terahertz (THz) frequency approach. A probe that could be implemented using inexpensive silicon technology is proposed, and it also permits integration of entire measuring tool for easy deployment. Skin cancer was chosen as it represents ~80% of all newly diagnosed cases and is the most common form of cancer in Australia. For an initial development and validation, due to data availability consideration in the open literature, basal cell carcinoma (BCC) was used for simulations. Methods and results: A probe, using high-frequency signals in the upper mm-wave frequency spectrum (90-300 GHz) to maximize the lateral resolution (mm precision) and allows the detection of tumors located at up to 0.5 mm deep in the skin, is proposed. A frequency-dependent relativity permittivity and an equivalent conductivity of skins were calculated based on the double Debye parameters. For the first time, electromagnetic (EM) models were generated and used along with a high-frequency EM simulator, ANSYS HFSS, to demonstrate the sensitivity of the concept. The following two scenarios were studied: in scenario one, a BCC layer of different thicknesses (10-3000 μm) was located on the top of the normal skin and, in scenario two, the BCC was embedded in normal skin at depths from 10 to 3000 μm. Variability using ±10% of the corresponding dielectric property was also considered. Conclusion: This study showed that the reflection coefficients vs frequency could capture useful information indicating the possible presence of BCC at mm-wave frequencies. Both magnitude and phase of the reflection coefficient were quantified, with two scenarios analyzed. It was found that a dual-band approach, 100-150 and 200-250 GHz, has the ability to highlight deviations from the normal skin.
Introduction
Skin cancer is the most common form of cancer in Australia, representing ~80% of all newly diagnosed cases, 1 with melanoma accounted for >10% of all reported incidence, in 2014 2 and 2017. 3 The majority of skin cancers are detected by patients themselves, or by their partners, while some are detected by physicians during the routine clinical examinations. There is no doubt that early detection could significantly reduce complications or mortality.
There are many patients in Australia who are known to be at moderate-to-high risk of nonmelanoma skin cancer or who have pigmented lesions, which are at risk of developing into melanoma. Today, it is possible to use dermoscopy to determine if the lesions are benign or suspicious and if they require excision for biopsy for conclusive diagnosis. However, it is more often the case that patients have lesions, which do not fulfill the criteria of malignancy but need ongoing monitoring. As with objective blood tests, which are reliable means of monitoring patients at risk of complications (such as deteriorating kidney function), irrespective of the circumstances of their medical examination, ideally, there should exist an accurate mean of assessing the patients for skin cancer too. Under the present health care system, no such objective measure exists.
Prospective total skin photography has been advocated as one method of picking up the onset of melanoma in patients with many atypical moles since it is more often the case that melanoma arises as a new lesion rather than as a changed existing lesion. However, when one has hundreds of moles, many of which are located on the back, it is unlikely that either the patient or the doctor who sees the patient once every 6 months can investigate all lesions without expensive photography and detailed review. If supplementary, detailed dermoscopic images are taken to investigate certain moles, specialized equipment and software are required at extra cost.
Existing imaging techniques for skin cancer diagnosis (such as total body photography and sequential imaging at the macroscopic level) have a low resolution. 4, 5 At the microscopic level, where higher resolution imaging can be achieved, invasive biopsy samples need to be imaged to determine the type and stage of the skin cancer.
The everlasting desire to improve the quality of life has heightened the competition to develop imaging techniques for health monitoring. Currently, optical coherence tomography, ultrasound, near-IR, and Raman spectroscopies, MRI, positron emission tomography, and X-ray techniques are receiving the most attention. [6] [7] [8] [9] [10] [11] [12] [13] [14] Some of these techniques offer nonionizing solutions, good resolution, good acquisition speeds, and well-targeted contrast mechanisms. However, none of them meets all of these crucial criteria simultaneously. Besides, most of them require costly and bulky equipment and tools.
Hence, it would be advantageous if there were a device, which could be used with a validated read out score, to indicate if particular lesions have reached the "at-risk" stage. This is of particular importance because, in Australia, there is an extensive list of patients waiting to be seen by a dermatologist. As a result, a large number of lesions are unnecessarily removed because of medicolegal and unstated financial incentives.
To overcome the problems above, we propose here the design of a practical small handheld device able to detect the responses of skin conditions (normal and basal cell carcinoma [BCC] ) from electromagnetic (EM) radiation at high mm-wave to low terahertz (THz) frequencies. This design represents a preamble for a follow-up sensitive, an integrated readout device, that can be made portable and that allows its deployment everywhere and anytime by any medical staff. A silicon millimeter (mm) mm-wave integrated circuit-type-based technology will ensure the reduced cost for mass deployment and implementation. This first study was conducted heavily relying on the existing open available data on BCC EM parameters. It is hoped that its success will give sufficient experience and background for other lethal cancers' electronic devices' studies.
Background
The high mm-wave to low THz signal range was chosen for our studies as it provides some unique features that make it particularly suitable for medical applications. For example, mm-waves have low generated photon energy 15, 16 not causing chemical damage to molecules or harmful ionization in biological tissues. Studies of high-power EM waves on human mammalian cells observed no significant differences between exposed and nonexposed cells, other than small temperature changes. 17 Also, mm-waves have very high absorption rates in water, marking them as responsive to characterize polar substances such as water and hydrated matter. 18, 19 Mm-waves' manipulation entails also smaller device sizes that are beneficial for cheap mass production.
We propose a novel device that would permit designing of a system that could quantify the reflected signal from the exposed skin area. The proposed technique is based on shining the skin tissue to a mm-wave so that the complex dielectric properties can be evaluated from this interaction. For different real and imaginary values of different skins, different reflections and absorptions occur, providing unique signatures. McAuley et al and others [20] [21] [22] showed that mmwave is able to provide high contrast on tissue depending on their water content. This contrast has been exploited before to map the water distribution in plants 23 and severely burnt skin samples. 21 Medical researchers have found that certain tumors have higher water content compared to healthy tissues. [24] [25] [26] [27] Researchers also showed that the water absorption of the mm-wave signal increases significantly with temperature. 28 Also, it has been concluded that in vivo tissue generally has higher water content compared to ex vivo tissue. 29 Therefore, the in vivo losses are more significant than the equivalent ones in the ex vivo samples at the room temperature.
During the past 2 decades, groups from around the globe conducted research on imaging with mm-waves and THz 33 The main drawbacks of using optical mixing systems are that they are bulky, expensive, and immovable. This is because these systems are primarily based on optical sources, mirrors, and lenses. To overcome these problems, more recent research shifts the focus to nearfield systems that use mm-waves' circuits. Sensors operating <40 GHz have been proposed and demonstrated; although they provide well-integrated solutions, their sensitivity is insufficient, due to the relatively large wavelengths. [34] [35] [36] Other systems, operating at much higher frequencies ~90 GHz, have shown promising results 22, 37 but are very bulky and not suitable for integration in a readout device with the small form factor.
In recent years, mm-wave technology has undergone dramatic advancements mostly as a result of the progress in silicon transistors and integrated circuits, making them suitable for operation throughout the entire mm-wave spectrum (30-300 GHz). Several large volume silicon mm-wave products, such as automotive cruise control radars 38, 39 and 60 GHz wireless USB3 transceivers operating at 5 Gb/s rates, 40 have demonstrated the feasibility and resilience of mm-wave silicon technology in the market. The costs of mm-wave silicon transceivers have also significantly diminished. Silicon mm-wave integrated circuits are now poised to take on and revolutionize a variety of new applications, where the medical imaging and diagnosis are among the most promising.
Methods
The suggested system consists of the following three parts: a signal generator-detector (eg, vector network analyser [VNA]), the proposed device itself, called "the probe", and the sample under test (skin area). The general practitioners or qualified personnel can use the probe by scanning it over the visually examined area of investigation. The key innovation of this work consists in designing a probe that offers a small footprint for high lateral resolution sensing with sufficient sensitivity for high contrast between the normal and diseased skin and also in the EM modeling of the BCC using existing data from the literature. The system is designed based on the principle of continuous-wave (CW) near-field EM wave reflectometry. The generated mm-wave signal illuminates the skin sample and travels through the probe; a part of the signal penetrates the sample with the remainder reflected through the probe and reached back the detector. This reflected signal gives unique information (in terms of its amplitude and phase) at different frequencies when compared with the transmitted signal from the generator. The deviances of the magnitude and phase of different skin samples from the normal skin are determined in this article. In the suggested system, the signal generator-detector could be a commercially available VNA, with the final aim to fabricate a fully integrated circuit combining the VNA function with the probe scanning feature, as future work. The probe is designed so that it permits limited penetration depth within typical skin thickness (eg, <3 mm). 41, 42, 43 The normal dry skin and the most common type of skin cancers BCC were considered in this study. For simplicity, a flat and homogeneous skin was assumed. The assumptions are valid provided that the simulated skin area (1.5 mm in diameter) is much smaller than the typical average BCC size, which is ~3-5 mm in diameter. 41 Also, the total skin thickness that consists of normal and BCC layers was limited here to 3 mm, as this is the typical maximum skin (epidermis-dermis) thickness across different body parts. 41, 42 There have been three steps in the present study. First, we calculated the variation of relative electrical permittivity and total effective conductivity functions vs frequencies. Second, the near-field reflectometry probe was designed. Finally, the combined probe-skin samples (treated as terminated/loaded probes) were studied and followed by their high frequency structure simulator (HFSS) simulations. The results accomplished in these steps are outlined later.
Step one: normal skin and BCC electrical parameters calculation
With CW EM simulations, typical commercially available software packages (eg, HFSS and CST) are unable to use complex frequency-dependent electric permittivity functions. Instead, they require the relative permittivity e r and the electric conductivity s.
However, human skin dielectric properties are typically modeled as complex frequency-dependent permittivity e*(ω), based on Debye theory. Pickwell et al 44 
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Chan and Ramer was able to use these parameters to perform simulations in the time domain with optical techniques to verify their designs that ultimately resulted in producing the only commercially available clinical hardware for skin cancer detection using TPI. 33 In our study, we perform EM modeling using Pickwell's double Debye parameters. Equation 1 was separated into the real (e′) and imaginary (e″) parts as in Equation (2):
The real part e′ represents the relative permittivity or e r , and the imaginary part e″ was further expressed as total effective conductivity (equivalent conductivity); permittivity is the ability of a substance to store electrical energy in an electric field. Electrical permittivity of free space is a universal constant e 0 =8.854×10 -12 F/m. Materials are characterized by the electrical permittivity e r e 0 =e′ [F/m] and e r is the relative permittivity and is >1. Materials can also be characterized by losses, which include dielectric damping and conductive loss. Together they form e″ and that can be expressed as the total effective conductivity equivalent conductivity.
s e of the material (skin) as in Equation (3) 
where e 0 =8.85×10 -12 F/m is the permittivity of free space and f is the frequency in Hz.
It should be noted that this total effective conductivity is not just the static (ionic) conductivity; it includes all the dielectric losses such as the standard static (ionic) conductivity and the associated loss (imaginary) terms from double Debye theory.
These calculations have been performed for each frequency point, ranging from 95 to 300 GHz, and are plotted in Figure 1 . In order to account for variability, ±10% of the BCC's relative permittivity e r and the total effective conductivity s e were also included.
Step two: probe considerations A typical coaxial type probe could be used as the sensor. Although some coaxial probes are commercially available, they are not suitable for this application as they suffer from having relatively large footprints. 45 Typically >3 mm in diameter, the commercial probes, which will also sense surrounding normal skin due to the fringing field, are not able to provide sufficient discrimination between normal skin, the BCC properties, and the surrounding normal skin. 46 Figure   2 illustrates the proposed rectangular waveguide probe that supports the transverse electric TE 10 mode for the sensing signal and that is easy to fabricate. The rectangular waveguide probe sits on the skin area of interest at one end and is connected to the VNA (generator and detector) through a coplanar waveguide transition at the other end. Front and back views of the skin sample in contact with the probe are shown in Figure 2A and B. A higher operational frequency, >90 GHz, is selected based on the lateral resolution and penetration considerations. In rectangular waveguide design, higher frequencies offer smaller waveguide cross-section due to waveguide cutoff frequency 44 and also provide shallower EM wave penetration in the skin. The lateral resolution and EM penetration must be adequately tackled. This is because BCC can be very shallow with a thickness in sub-mm range and can have a lateral dimensions of order of mm 2 . Glass was selected as the waveguide filling material due to its wide commercial availability for microfabrication. Glass also has a dielectric constant of 5.5, which is the closest to 5.6 value that is attributed to the normal skin, 47 allowing the minimization of the impedance mismatch between the probe and normal skin at the contact interface. This permits the mm-wave signal to penetrate into the skin and allows to take place only when mismatch 46 occurs. As BCC exhibits departure from the dielectric constant and conductivity values of the normal skin, a mismatch will be encountered and this can be quantified by measuring the reflection coefficient.
With the selection of sensing frequencies >95 GHz and glass as filling material for the probe, a minimal footprint, as small as 0.7 mm (W)×0.35 mm (H) can be achieved. Also, as the sensing frequency is >95 GHz and operation is in the near-field EM radiation condition, the system is interference immune. It will offer interference avoidance from existing far-field communication and military systems, operating at frequencies <100 GHz.
Step three: probe loaded with skin samples study An entire combination of the probe loaded with different skin samples was simulated in HFSS. The EM signal was excited from the generator (the VNA), has traveled through the probe, was reflected from the skin, and has returned back to the detector (the VNA). Two possible occurring scenarios were considered in order to emulate different BCC conditions.
In scenario 1, a shallow BCC layer of various thicknesses is located on the top of the normal skin, as shown in Figure  3A . Figure 3B and C shows the EM simulation set-up and the TE 10 mode propagation for scenario 1. 
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In scenario 2, a 500 μm thick BCC layer is embedded under the normal skin at various depths, as shown in Figure  3D . Figure 3E and F shows the EM simulation set-up and the illustration of the TE 10 mode propagation for scenario 2.
Results and discussion
The HFSS-simulated reflected signals were analyzed in terms of the magnitude (|S 11 | in dB) and phase (∠S 11 in degrees) of the reflection coefficient, for both scenarios 1 and 2. These results were compared with the magnitude |S 11 | and phase ∠S 11 of the reflection coefficient for the normal skin that are given in Figure 4 .
We note that for frequency ranging between 150 and 300 GHz, the magnitude |S 11 | takes values <-20 dB. Therefore, in order to effectively emphasize the effectiveness of the proposed system, the results were presented as differences between the magnitudes and phases of the reflection coefficients where the BCC values were considered first and then the normal skin, ie, Δ|S 11 | = |S 11 | BCC -|S 11 | normal skin and Δ∠S 11 = ∠S 11BCC -∠S 11normal skin . The study results for scenarios 1 and 2 are illustrated in Figures 5 and 6 , where ±10% variations in relative permittivity e r and total effective conductivity s e were introduced (eg, e r =90% and 110% and s e =90% and 110% of the original calculated functions), to account for possible variability.
For scenario 1, Figure 5A -E shows the differences in magnitude of the reflection coefficient Δ|S 11 |, while Figure  5F -J illustrates the phase differences Δ∠S 11 of BCC of different thicknesses (10, 50, 100, 500, 1000, and 3000 μm) and normal skin, over the entire frequency range, with ±10% variations in relative permittivity e r and conductivity s e of the BCC. According to these results, even a very shallow BCC layer resulted in a distinguishable difference in magnitude response compared to normal skin. This is even more pronounced for the difference in phase response, where other than the 10 μm thin BCC layer, a large phase deviation from the normal skin phase is observed, in particular >200 GHz. Figure 6A -J shows the simulation results for the second scenario, where a 500 μm thick BCC layer is embedded in a normal skin layer at progressive depths 10, 50, 100, 500, 1000, and 3000 μm with ±10% variations in relative permittivity e r and conductivity s e of the BCC. Clearly, notable differences in magnitude |S 11 | (Figure 6A -E) and phase ∠S 11 ( Figure 6F -J) values could be captured for all BCC layers embedded at depths from 10 to 100 μm, within these variations. In fact, the shallower the BCC layer is embedded under normal skin tissue, the more differences to the Δ|S 11 | and Δ∠S 11 from those for the normal skin. It should be noted that according to the simulations, as the BCC layer is embedded >500 μm under the normal skin, the responses from both magnitude and phase become similar to normal skin, across the entire 95-300 GHz frequency range. This is, in fact, a desirable feature for the proposed probe. According to researchers, 48 the device should only detect unusual tissues that are embedded in the epidermis layer, which has a typical thickness of <100 μm across body sites.
The difference in magnitude shows <2 dB values >200 GHz for scenario 1, and the difference in magnitude shows >3 dB values <200 GHz for scenario 2, as shown in Figures 5 and 6 , respectively. As magnitude |S 11 | for the reference normal skin is <-20 dB >200 GHz, the absolute magnitudes for both scenarios are only ~-20 dB, which correspond to very small values. This is not the case for the differences in phase, Δ∠S 11 data, where significant values were obtained, rendering the phase as the preferred parameter for our analysis. Therefore, a dual-band operation (95-150 and 200-250 GHz) is ideal, where magnitude and phase are the preferred parameters, respectively, for the BCC detection. Dual-band approach will not pose any difficulty in silicon technology implementation. 49 With the proposed concept, the following advantages could be achieved: The small footprint of the probe for high lateral resolution (~mm) sensing; Controlled sensing depth into the skin, suitable for 100 μm deep embedded BCC; High contrast between normal skin and BCC, for satisfactory sensitivity; Cheap silicon technology implementation; Integration with on-chip VNA for an ultimate small, hand-held portable device that can easily be deployed anywhere.
The present study reveals that the proposed technique has the potential to detect BCC presence; however, at this stage, it cannot provide absolute location and thickness information. In fact, as suggested in Truong et al, 50 normal skin and BCC could result in very different dielectric properties depending on the person, the body parts, modeling, and measurement techniques. Therefore, this proposed technique is valid and Figure 5 Simulation results of scenario 1 (BCC layer with thickness 10, 50, 100, 500, 1000, and 3000 μm on the surface of healthy skin): (A-E) shows differences in magnitude (Δ|S11|) and (F-J) shows phase (Δ∠S11) of the reflection coefficient, with ±10% variation of BCC's e r and s e . Abbreviation: BCC, basal cell carcinoma. Figure 6 Simulation results of scenario 2 (BCC layer embedded in healthy skin at depths of 10, 50, 100, 500, 1000, and 3000 μm): (A-E) shows differences in magnitude (Δ|S11|) and (F-J) shows phase (Δ∠S11) of the reflection coefficient, with ±10% variation of BCC's e r and s e . Abbreviation: BCC, basal cell carcinoma. 
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Chan and Ramer offers useful information only when BCC is referenced to the adjacent normal skin. Future studies including detailed mathematical modeling and classifications are required in order to further determine the thickness, the location, and dielectric properties over a frequency range.
Conclusion
Studies and simulation results of a mm-wave rectangular glass filled probe using CW were carried out for the detection of skin conditions. In this study, normal skin and BCC skin EM models, with ±10% variation in the BCC complex dielectric properties, were created and simulated with a high-frequency EM simulator ANSYS HFSS. The simulation results validated that the technique provides a satisfactory sensitivity to detect BCC while providing a small footprint and adequate sensing depth. Depending on the frequency range, either amplitude or phase could be the preferred parameter for the detection of maximum contrast between BCC and normal skin. We concluded that a dual-band system in silicon implementation could be ideal for this application. While a VNA was proposed as a transmitter and receiver in conjunction with the probe, the authors hope that the present work can be extended to an advanced fabricated VNA probe integrated into a single small device in the future, providing a preamble to a compact handheld portable device that can be easily deployed and used. It should be noted that although this concept was validated in simulations, a final decisive conclusion of the usefulness of this concept should only be made after performing in vivo experiments. Hence the next step to validate this concept is to perform a preclinical study using animal models 51 consisting BCC and normal control skins followed by in vitro study with human skin samples. A statistical study should also be performed to validate its sensitivity and specificity.
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